The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells

Cell Transplantation

Volumn 20, Issue 1, 2011, Pages 85-94

  Sanberg, Paul R ^a,b   Eve, David J ^a   Willing, Alison E ^a   Garbuzova Davis, Svitlana ^a   Tan, Jun ^a   Sanberg, Cyndy D ^c   Allickson, Julie G ^d   Cruz, L Eduardo ^e   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Saneron CCEL Therapeutics Inc   (United States)

^d Cryo Cell International Inc   (United States)

^e Cryopraxis   (Brazil)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Menstrual derived stem cells; Sanfilippo syndrome; Stroke; Umbilical cord blood

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE RECEPTOR CX3CR1; CYTOKINE; FRACTALKINE; GROWTH FACTOR; NEUROTROPHIN 3; PRESENILIN; VASCULOTROPIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANEMIA; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BLOOD; BRAIN ISCHEMIA; CELL MATURATION; CELL POPULATION; CELL SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; HEART INFARCTION; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; HUNTINGTON CHOREA; LEUKEMIA; LYMPHOMA; MENSTRUAL BLOOD; MENSTRUAL BLOOD STEM CELL; MONONUCLEAR CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SANFILIPPO SYNDROME; SPINAL CORD INJURY; STEM CELL; STEM CELL TRANSPLANTATION; STROKE; TRAUMATIC BRAIN INJURY;

ADULT STEM CELLS; BLOOD CELLS; FETAL BLOOD; HUMANS; NEURODEGENERATIVE DISEASES; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 79952528345     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X532855     Document Type: Review

References (113)

1. Advani, A. S.; Laughlin, M. J. Umbilical cord blood transplantation for acute myeloid leukemia. Curr. Opin. Hematol. 16(2):124-128; 2009.
2. Alexianu, M. E.; Kozovska, M.; Appel, S. H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57(7):1282-1289; 2001.
3. Aloisi, F. Immune function of microglia. Glia 36(2):165-179; 2001.
4. Appel, S. H.; Smith, R. G.; Engelhardt, J. I.; Stefani, E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J. Neurol. Sci. 124(Suppl.):14-19; 1994.
5. Arien-Zakay, H.; Lecht, S.; Bercu, M. M.; Tabakman, R.; Kohen, R.; Galski, H.; Nagler, A.; Lazarovici, P. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp. Neurol. 216(1):83-94; 2009.
6. Bachstetter, A. D.; Morganti, J. M.; Jernberg, J.; Schlunk, A.; Mitchell, S. H.; Brewster, K. W.; Hudson, C. E.; Cole, M. J.; Harrison, J. K.; Bickford, P. C.; Gemma, C. Fractalkine and CX(3)CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging; in press.
7. Bachstetter, A. D.; Pabon, M. M.; Cole, M. J.; Hudson, C. E.; Sanberg, P. R.; Willing, A. E.; Bickford, P. C.; Gemma, C. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci. 9:22; 2008.
8. Benzing, W. C.; Wujek, J. R.; Ward, E. K.; Shaffer, D.; Ashe, K. H.; Younkin, S. G.; Brunden, K. R. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol. Aging 20(6):581-589; 1999.
9. Borlongan, C. V.; Hadman, M.; Sanberg, C. D.; Sanberg, P. R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35(10):2385-2389; 2004.
10. Borlongan, C. V.; Kaneko, Y.; Maki, M.; Yu, S.; Ali, M. M.; Allickson, J.; Sanberg, C.; Kuzmin-Nichols, N.; Sanberg, P. R. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev. 19(4):439-452; 2010.
11. Burke, M. J.; Cao, Q.; Trotz, B.; Weigel, B.; Kumar, A.; Smith, A.; Verneris, M. R. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphocal blastic leukemia (ALL). Pediatr. Blood Cancer 53(7):1289-1294; 2009.
12. Butovsky, O.; Koronyo-Hamaoui, M.; Kunis, G.; Ophir, E.; Landa, G.; Cohen, H.; Schwartz, M. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA 103(31):11784-11789; 2006.
13. Calingasan, N. Y.; Erdely, H. A.; Altar, C. A. Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury. Neurobiol. Aging 23(1):31-39; 2002.
14. Cardona, A. E.; Pioro, E. P.; Sasse, M. E.; Kostenko, V.; Cardona, S. M.; Dijkstra, I. M.; Huang, D.; Kidd, G.; Dombrowski, S.; Dutta, R.; Lee, J. C.; Cook, D. N.; Jung, S.; Lira, S. A.; Littman, D. R.; Ransohoff, R. M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9(7):917-924; 2006.
15. Chen, C. T.; Foo, N. H.; Liu, W. S.; Chen, S. H. Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms. Pediatr. Neonatol. 49(3):77-83; 2008.
16. Chen, R.; Ende, N. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J. Med. 31(1-2):21-30; 2000.
17. Cho, N. H.; Park, Y. K.; Kim, Y. T.; Yang, H.; Kim, S. K. Lifetime expression of stem cell markers in the uterine endometrium. Fertil. Steril. 81(2):403-407; 2004.
18. Chung, D. J.; Choi, C. B.; Lee, S. H.; Kang, E. H.; Lee, J. H.; Hwang, S. H.; Han, H.; Lee, J. H.; Choe, B. Y.; Lee, S. Y.; Kim, H. Y. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J. Neurosci. Res. 87(16):3554-3567; 2009.
19. Clausen, B. H.; Lambertsen, K. L.; Babcock, A. A.; Holm, T. H.; Dagnaes-Hansen, F.; Finsen, B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflammation 5:46; 2008.
20. Colton, C. A.; Mott, R. T.; Sharpe, H.; Xu, Q.; Van Nostrand, W. E.; Vitek, M. P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 3:27; 2006.
21. Cui, C. H.; Uyama, T.; Miyado, K.; Terai, M.; Kyo, S.; Kiyono, T.; Umezawa, A. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol. Biol. Cell 18(5):1586-1594; 2007.
22. Desideri, G.; Cipollone, F.; Necozione, S.; Marini, C.; Lechiara, M. C.; Taglieri, G.; Zuliani, G.; Fellin, R.; Mezzetti, A.; di Orio, F.; Ferri, C. Enhanced soluble CD40 ligand and Alzheimer's disease: Evidence of a possible pathogenetic role. Neurobiol. Aging 29(3):348-356; 2008.
23. Duan, R. S.; Yang, X.; Chen, Z. G.; Lu, M. O.; Morris, C.; Winblad, B.; Zhu, J. Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice. Neurochem. Res. 33(6):1085-1089; 2008.
24. Ende, M.; Ende, N. Hematopoietic transplantation by means of fetal (cord) blood. A new method. VA Med. Mon. 99:276-280; 1972.
25. Ende, N.; Chen, R. Human umbilical cord blood cells ameliorate Huntington's disease in transgenic mice. J. Med. 32(3-4):231-240; 2001.
26. Ende, N.; Chen, R. Parkinson's disease mice and human umbilical cord blood. J. Med. 33(1-4):173-180; 2002.
27. Ende, N.; Chen, R.; Ende-Harris, D. Human umbilical cord blood cells ameliorate Alzheimer's disease in transgenic mice. J. Med. 32(3-4):241-247; 2001.
28. Ende, N.; Chen, R.; Reddi, A. S. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem. Biophys. Res. Commun. 325(3):665-669; 2004.
29. Ende, N.; Ende, M.; Chen, R.; Coakley, K.; Reddi, A. S. Prevention of atherosclerosis in LDL receptor-mutant mice by human umbilical cord blood cells. Res. Commun. Mol. Pathol. Pharmacol. 117-118:125-136; 2005.
30. Ende, N.; Weinstein, F.; Chen, R.; Ende, M. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci. 67(1):53-59; 2000.
31. Eve, D. J.; Musso, 3rd, J.; Park, D. H.; Bui, V.; Smith, A.; Cameron, D.; Oliveira, C.; Pollock, K.; Hope, A.; Baradez, M.-O.; Sinden, J. D.; Sanberg, P. R. Regulated changes in trophic factor secretion by a neural stem cell and its angiogenic response. Cell Transplant. 18(2):213; 2009.
32. Fruchtman, S. M.; Hurlet, A.; Dracker, R.; Isola, L.; Goldman, B.; Schneider, B. L.; Emre, S. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biol. Blood Marrow Transplant. 10(11):741-742; 2004.
33. Garbuzova-Davis, S.; Gografe, S. J.; Sanberg, C. D.; Willing, A. E.; Saporta, S.; Cameron, D. F.; Desjarlais, T.; Daily, J.; Kuzmin-Nichols, N.; Chamizo, W.; Klasko, S. K.; Sanberg, P. R. Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in Sanfilippo type B mouse model. FASEB J. 20(3):485-487; 2006.
34. Garbuzova-Davis, S.; Klasko, S. K.; Sanberg, P. R. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B. J. Comp. Neurol. 515(1):93-101; 2009.
35. Garbuzova-Davis, S.; Louis, M.; Woods, R. I.; Wells, L.; Klasko, S. K.; Sanberg, P. R. Functional and structural impairment of blood-brain barrier in a mouse model of Sanfilippo Type B. Cell Transplant. 19(3):339-340; 2010.
36. Garbuzova-Davis, S.; Sanberg, C. D.; Kuzmin-Nichols, N.; Willing, A. E.; Gemma, C.; Bickford, P. C.; Miller, C.; Rossi, R.; Sanberg, P. R. Human umbilical cord blood treatment in a mouse model of ALS: Optimization of cell dose. PLoS One 3(6):e2494; 2008.
37. Garbuzova-Davis, S.; Saporta, S.; Haller, E.; Kolomey, I.; Bennett, S. P.; Potter, H.; Sanberg, P. R. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2(11):e1205; 2007.
38. Garbuzova-Davis, S.; Willing, A. E.; Desjarlais, T.; Davis Sanberg, C.; Sanberg, P. R. Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B. Stem Cells Dev. 14(4):384-394; 2005.
39. Garbuzova-Davis, S.; Willing, A. E.; Zigova, T.; Saporta, S.; Justen, E. B.; Lane, J. C.; Hudson, J. E.; Chen, N.; Davis, C. D.; Sanberg, P. R. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: Distribution, migration, and differentiation. J. Hematother. Stem Cell Res. 12(3):255-270; 2003.
40. Garbuzova-Davis, S.; Xie, Y.; Danias, P.; Sanberg, C. D.; Klasko, S. K.; Sanberg, P. R. Transplantation of cord blood monocyte/macrophage cells to treat Sanfilippo Type B. Cell Transplant. 17(4):466-467; 2008.
41. Garbuzova-Davis, S.; Xie, Y.; Zayko, O.; Sanberg, P. R. Human umbilical cord blood cells in treatment of Sanfilippo syndrome type B. Cell Transplant. 18(2):214-215; 2009.
42. Gemma, C.; Bachstetter, A. D.; Cole, M. J.; Fister, M.; Hudson, C.; Bickford, P. C. Blockade of caspase-1 increases neurogenesis in the aged hippocampus. Eur. J. Neurosci. 26(10):2795-2803; 2007.
43. Gluckman, E.; Broxmeyer, H. A.; Auerbach, A. D.; Friedman, H. S.; Douglas, G. W.; Devergie, A.; Esperou, H.; Thierry, D.; Socie, G.; Lehn, P.; et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321(17):1174-1178; 1989.
44. Hall, A. A.; Leonardo, C. C.; Collier, L. A.; Rowe, D. D.; Willing, A. E.; Pennypacker, K. R. Delayed treatments for stroke influence neuronal death in rat organotypic slice cultures subjected to oxygen glucose deprivation. Neuroscience 164(2):470-477; 2009.
45. Halle, A.; Hornung, V.; Petzold, G. C.; Stewart, C. R.; Monks, B. G.; Reinheckel, T.; Fitzgerald, K. A.; Latz, E.; Moore, K. J.; Golenbock, D. T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9(8):857-865; 2008.
46. Haller, M. J.; Viener, H. L.; Wasserfall, C.; Brusko, T.; Atkinson, M. A.; Schatz, D. A. Autologous umbilical cord blood infusion for type 1 diabetes. Exp. Hematol. 36(6):710-715; 2008.
47. Henning, R. J.; Burgos, J. D.; Vasko, M.; Alvarado, F.; Sanberg, C. D.; Sanberg, P. R.; Morgan, M. B. Human cord blood cells and myocardial infarction: Effect of dose and route of administration on infarct size. Cell Transplant. 16(9):907-917; 2007.
48. Hida, N.; Nishiyama, N.; Miyoshi, S.; Kira, S.; Segawa, K.; Uyama, T.; Mori, T.; Miyado, K.; Ikegami, Y.; Cui, C.; Kiyono, T.; Kyo, S.; Shimizu, T.; Okano, T.; Sakamoto, M.; Ogawa, S.; Umezawa, A. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 26(7):1695-1704; 2008.
49. Jiang, L.; Newman, M.; Saporta, S.; Chen, N.; Sanberg, C.; Sanberg, P. R.; Willing, A. E. MIP-1alpha and MCP-1 induce migration of human umbilical cord blood cells in models of stroke. Curr. Neurovasc. Res. 5(2):118-124; 2008.
50. Jiang, L.; Womble, T. A.; Saporta, S.; Chen, N.; Sanberg, C. D.; Sanberg, P. R.; Willing, A. Human umbilical cord blood cells decrease microglial survival in vitro. Stem Cells Dev. 19(2):221-228; 2010.
51. Jimenez, S.; Baglietto-Vargas, D.; Caballero, C.; Moreno-Gonzalez, I.; Torres, M.; Sanchez-Varo, R.; Ruano, D.; Vizuete, M.; Gutierrez, A.; Vitorica, J. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: Age-dependent switch in the microglial phenotype from alternative to classic. J. Neurosci. 28(45):11650-11661; 2008.
52. Kang, H. J.; Lee, J. W.; Kim, H.; Shin, H. Y.; Ahn, H. S. Successful first-line treatment with double umbilical cord blood transplantation in severe aplastic anemia. Bone Marrow Transplant. 45(5):955-956; 2010.
53. Kawamata, T.; Akiyama, H.; Yamada, T.; McGeer, P. L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140(3):691-707; 1992.
54. Kelly, P.; Kurtzberg, J.; Vichinsky, E.; Lubin, B. Umbilical cord blood stem cells: Application for the treatment of patients with hemoglobinopathies. J. Pediatr. 130(5):695-703; 1997.
55. Kim, T. S.; Lim, H. K.; Lee, J. Y.; Kim, D. J.; Park, S.; Lee, C.; Lee, C. U. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Neurosci. Lett. 436(2):196-200; 2008.
56. Kuh, S. U.; Cho, Y. E.; Yoon, D. H.; Kim, K. N.; Ha, Y. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir. (Wien) 147(9):985-992; 2005.
57. Kurozumi, K.; Nakamura, K.; Tamiya, T.; Kawano, Y.; Ishii, K.; Kobune, M.; Hirai, S.; Uchida, H.; Sasaki, K.; Ito, Y.; Kato, K.; Honmou, O.; Houkin, K.; Date, I.; Hamada, H. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol. Ther. 11(1):96-104; 2005.
58. Laporte, V.; Ait-Ghezala, G.; Volmar, C. H.; Mullan, M. CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models. J. Neuroinflammation 3:3; 2006.
59. Lee, J. K.; Jin, H. K.; Bae, J. S. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci. Lett. 450(2):136-141; 2009.
60. Lee, J. K.; Jin, H. K.; Endo, S.; Schuchman, E. H.; Carter, J. E.; Bae, J. S. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 28(2):329-343; 2010.
61. Leonardo, C. C.; Hall, A. A.; Collier, L. A.; Ajmo, Jr., C. T.; Willing, A. E.; Pennypacker, K. R. Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11b-expressing, isolectin-binding proinflammatory cells after middle cerebral artery occlusion. J. Neurosci. Res. 88(6):1213-1222; 2010.
62. Li, H. H.; Yu, W. H.; Rozengurt, N.; Zhao, H. Z.; Lyons, K. M.; Anagnostaras, S.; Fanselow, M. S.; Suzuki, K.; Vanier, M. T.; Neufeld, E. F. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc. Natl. Acad. Sci. USA 96(25):14505-14510; 1999.
63. Locatelli, F.; Rocha, V.; Reed, W.; Bernaudin, F.; Ertem, M.; Grafakos, S.; Brichard, B.; Li, X.; Nagler, A.; Giorgiani, G.; Haut, P. R.; Brochstein, J. A.; Nugent, D. J.; Blatt, J.; Woodard, P.; Kurtzberg, J.; Rubin, C. M.; Miniero, R.; Lutz, P.; Raja, T.; Roberts, I.; Will, A. M.; Yaniv, I.; Vermylen, C.; Tannoia, N.; Garnier, F.; Ionescu, I.; Walters, M. C.; Lubin, B. H.; Gluckman, E. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 101(6):2137-2143; 2003.
64. Lu, D.; Sanberg, P. R.; Mahmood, A.; Li, Y.; Wang, L.; Sanchez-Ramos, J.; Chopp, M. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 11(3):275-281; 2002.
65. Macri, R.; Sanberg, P. R.; Xie, Y.; Ismail, Z.; Vergo, T.; Garbuzova-Davis, S. Endothelial cells derived from human umbilical cord blood as a potential cell source to restore the damaged blood-brain barrier in ALS. Cell Transplant. 17(4):473-474; 2008.
66. Makinen, S.; Kekarainen, T.; Nystedt, J.; Liimatainen, T.; Huhtala, T.; Narvanen, A.; Laine, J.; Jolkkonen, J. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res. 1123(1):207-215; 2006.
67. Malinin, N. L.; Wright, S.; Seubert, P.; Schenk, D.; Griswold-Prenner, I. Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity. Proc. Natl. Acad. Sci. USA 102(8):3058-3063; 2005.
68. Meier, C.; Middelanis, J.; Wasielewski, B.; Neuhoff, S.; Roth-Haerer, A.; Gantert, M.; Dinse, H. R.; Dermietzel, R.; Jensen, A. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr. Res. 59(2):244-249; 2006.
69. Meng, X.; Ichim, T. E.; Zhong, J.; Rogers, A.; Yin, Z.; Jackson, J.; Wang, H.; Ge, W.; Bogin, V.; Chan, K. W.; Thebaud, B.; Riordan, N. H. Endometrial regenerative cells: A novel stem cell population. J. Transl. Med. 5:57; 2007.
70. Miller, C.; Sanberg, P. R.; Kuzmin-Nichols, N.; Garbuzova-Davis, S. Reduction of activated microglia in the spinal cord of ALS mice with optimal dose of human umbilical cord blood cells. Cell Transplant. 19(3):352-353; 2010.
71. Miller, C.; Sanberg, P. R.; Kuzmin-Nichols, N.; Sanberg, C. D.; Garbuzova-Davis, S. Optimal dose of human umbilical cord blood cells reduced spinal cord microglia in G93A Sod1 mice modeling ALS. Cell Transplant. 18(2): 226; 2009.
72. Musina, R. A.; Belyavski, A. V.; Tarusova, O. V.; Solovyova, E. V.; Sukhikh, G. T. Endometrial mesenchymal stem cells isolated from the menstrual blood. Bull. Exp. Biol. Med. 145(4):539-543; 2008.
73. Nan, Z.; Grande, A.; Sanberg, C. D.; Sanberg, P. R.; Low, W. C. Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann. NY Acad. Sci. 1049:84-96; 2005.
74. Newcomb, J. D.; Ajmo, Jr., C. T.; Sanberg, C. D.; Sanberg, P. R.; Pennypacker, K. R.; Willing, A. E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 15(3):213-223; 2006.
75. Newman, M. B.; Davis, C. D.; Borlongan, C. V.; Emerich, D.; Sanberg, P. R. Transplantation of human umbilical cord blood cells in the repair of CNS diseases. Expert Opin. Biol. Ther. 4(2):121-130; 2004.
76. Newman, M. B.; Willing, A. E.; Manresa, J. J.; Davis-Sanberg, C.; Sanberg, P. R. Stroke-induced migration of human umbilical cord blood cells: Time course and cytokines. Stem Cells Dev. 14(5):576-586; 2005.
77. Newman, M. B.; Willing, A. E.; Manresa, J. J.; Sanberg, C. D.; Sanberg, P. R. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: Implications for brain repair. Exp. Neurol. 199(1):201-208; 2006.
78. Niebroj-Dobosz, I.; Jamrozik, Z.; Janik, P.; Hausmanowa-Petrusewicz, I.; Kwiecinski, H. Anti-neural anti-bodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol. Scand. 100(4):238-243; 1999.
79. Nikolic, W. V.; Hou, H.; Town, T.; Zhu, Y.; Giunta, B.; Sanberg, C. D.; Zeng, J.; Luo, D.; Ehrhart, J.; Mori, T.; Sanberg, P. R.; Tan, J. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev. 17(3):423-439; 2008.
80. Nystedt, J.; Makinen, S.; Laine, J.; Jolkkonen, J. Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiol. Exp. (Wars) 66:293-300; 2006.
81. Ohtaki, H.; Ylostalo, J. H.; Foraker, J. E.; Robinson, A. P.; Reger, R. L.; Shioda, S.; Prockop, D. J. Stem/ progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/ immune responses. Proc. Natl. Acad. Sci. USA 105(38):14638-14643; 2008.
82. Park, D. H.; Borlongan, C. V.; Willing, A. E.; Eve, D. J.; Cruz, L. E.; Sanberg, C. D.; Chung, Y. G.; Sanberg, P. R. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 18(9):985-998; 2009.
83. Park, D. H.; Eve, D. J.; Musso, 3rd, J.; Klasko, S. K.; Cruz, E.; Borlongan, C. V.; Sanberg, P. R. Inflammation and stem cell migration to the injured brain in higher organisms. Stem Cells Dev. 18(5):693-702; 2009.
84. Patel, A. N.; Park, E.; Kuzman, M.; Benetti, F.; Silva, F. J.; Allickson, J. G. Multipotent menstrual blood stromal stem cells: Isolation, characterization, and differentiation. Cell Transplant. 17(3):303-311; 2008.
85. Pimentel-Coelho, P. M.; Magalhaes, E. S.; Lopes, L. M.; Deazevedo, L. C.; Santiago, M. F.; Mendez-Otero, R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: Functional outcome related to neuroprotection in the striatum. Stem Cells Dev. 19(3):351-358; 2010.
86. Pisati, F.; Bossolasco, P.; Meregalli, M.; Cova, L.; Belicchi, M.; Gavina, M.; Marchesi, C.; Calzarossa, C.; Soligo, D.; Lambertenghi-Deliliers, G.; Bresolin, N.; Silani, V.; Torrente, Y.; Polli, E. Induction of neurotrophin expression via human adult mesenchymal stem cells: Implication for cell therapy in neurodegenerative diseases. Cell Transplant. 16(1):41-55; 2007.
87. Ponomarev, E. D.; Maresz, K.; Tan, Y.; Dittel, B. N. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J. Neurosci. 27(40):10714-10721; 2007.
88. Rizvanov, A. A.; Kiyasov, A. P.; Gaziziov, I. M.; Yilmaz, T. S.; Kaligin, M. S.; Andreeva, D. I.; Shafigullina, A. K.; Guseva, D. S.; Kiselev, S. L.; Matin, K.; Palotas, A.; Islamov, R. R. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis - a novel approach in stem cell therapy. Neurochem. Int. 53(6-8):389-394; 2008.
89. Rocha, V.; Cornish, J.; Sievers, E. L.; Filipovich, A.; Locatelli, F.; Peters, C.; Remberger, M.; Michel, G.; Arcese, W.; Dallorso, S.; Tiedemann, K.; Busca, A.; Chan, K. W.; Kato, S.; Ortega, J.; Vowels, M.; Zander, A.; Souillet, G.; Oakill, A.; Woolfrey, A.; Pay, A. L.; Green, A.; Garnier, F.; Ionescu, I.; Wernet, P.; Sirchia, G.; Rubinstein, P.; Chevret, S.; Gluckman, E. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97(10):2962-2971; 2001.
90. Rocha, V.; Kabbara, N.; Ionescu, I.; Ruggeri, A.; Purtill, D.; Gluckman, E. Pediatric related and unrelated cord blood transplantation for malignant diseases. Bone Marrow Transplant. 44(10):653-659; 2009.
91. Rocha, V.; Labopin, M.; Sanz, G.; Arcese, W.; Schwerdtfeger, R.; Bosi, A.; Jacobsen, N.; Ruutu, T.; de Lima, M.; Finke, J.; Frassoni, F.; Gluckman, E. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 351(22):2276-2285; 2004.
92. Rozemuller, A. J.; van Gool, W. A.; Eikelenboom, P. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: Therapeutic implications. Curr. Drug Targets CNS Neurol. Disord. 4(3):223-233; 2005.
93. Sanberg, P. R.; Park, D. H.; Kuzmin-Nichols, N.; Cruz, E.; Hossne, Jr., N. A.; Buffolo, E.; Willing, A. E. Monocyte transplantation for neural and cardiovascular ischemia repair. J. Cell. Mol. Med. 14(3):553-563; 2010.
94. Saporta, S.; Kim, J. J.; Willing, A. E.; Fu, E. S.; Davis, C. D.; Sanberg, P. R. Human umbilical cord blood stem cells infusion in spinal cord injury: Engraftment and beneficial influence on behavior. J. Hematother. Stem Cell Res. 12(3):271-278; 2003.
95. Schwab, K. E.; Chan, R. W.; Gargett, C. E. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertil. Steril. 84(Suppl. 2):1124-1130; 2005.
96. Sun, Y.; Jin, K.; Xie, L.; Childs, J.; Mao, X. O.; Logvinova, A.; Greenberg, D. A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111(12):1843-1851; 2003.
97. Taguchi, A.; Soma, T.; Tanaka, H.; Kanda, T.; Nishimura, H.; Yoshikawa, H.; Tsukamoto, Y.; Iso, H.; Fujimori, Y.; Stern, D. M.; Naritomi, H.; Matsuyama, T. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114(3):330-338; 2004.
98. Tan, J.; Town, T.; Crawford, F.; Mori, T.; DelleDonne, A.; Crescentini, R.; Obregon, D.; Flavell, R. A.; Mullan, M. J. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Nat. Neurosci. 5(12):1288-1293; 2002.
99. Tan, J.; Town, T.; Paris, D.; Mori, T.; Suo, Z.; Crawford, F.; Mattson, M. P.; Flavell, R. A.; Mullan, M. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286(5448):2352-2355; 1999.
100. Todd Roach, J.; Volmar, C. H.; Dwivedi, S.; Town, T.; Crescentini, R.; Crawford, F.; Tan, J.; Mullan, M. Behavioral effects of CD40-CD40L pathway disruption in aged PSAPP mice. Brain Res. 1015(1-2):161-168; 2004.
101. Townsend, K. P.; Town, T.; Mori, T.; Lue, L. F.; Shytle, D.; Sanberg, P. R.; Morgan, D.; Fernandez, F.; Flavell, R. A.; Tan, J. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid betapeptide. Eur. J. Immunol. 35(3):901-910; 2005.
102. Vendrame, M.; Cassady, J.; Newcomb, J.; Butler, T.; Pennypacker, K. R.; Zigova, T.; Sanberg, C. D.; Sanberg, P. R.; Willing, A. E. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35(10):2390-2395; 2004.
103. Vendrame, M.; Gemma, C.; de Mesquita, D.; Collier, L.; Bickford, P. C.; Sanberg, C. D.; Sanberg, P. R.; Penny-packer, K. R.; Willing, A. E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 14(5):595-604; 2005.
104. Wang, Y.; Lin, S. Z.; Chiou, A. L.; Williams, L. R.; Hoffer, B. J. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J. Neurosci. 17(11):4341-4348; 1997.
105. Willing, A. E.; Lixian, J.; Milliken, M.; Poulos, S.; Zigova, T.; Song, S.; Hart, C.; Sanchez-Ramos, J.; Sanberg, P. R. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 73:296-307; 2003.
106. + human umbilical cord blood cells are essential for neurological recovery following MCAO. Cell Transplant. 18(2):240; 2009.
107. Xiao, J.; Nan, Z.; Motooka, Y.; Low, W. C. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev. 14(6):722-733; 2005.
108. Yamanaka, K.; Chun, S. J.; Boillee, S.; Fujimori-Tonou, N.; Yamashita, H.; Gutmann, D. H.; Takahashi, R.; Misawa, H.; Cleveland, D. W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11(3):251-253; 2008.
109. Yasuhara, T.; Hara, K.; Maki, M.; Xu, L.; Yu, G.; Ali, M. M.; Masuda, T.; Yu, S. J.; Bae, E. K.; Hayashi, T.; Matsukawa, N.; Kaneko, Y.; Kuzmin-Nichols, N.; Ellovitch, S.; Cruz, E. L.; Klasko, S. K.; Sanberg, C. D.; Sanberg, P. R.; Borlongan, C. V. Mannitol facilitates neurotrophic factor upregulation and behavioral recovery in neonatal hypoxic-ischemic rats with human umbilical cord blood grafts. J. Cell. Mol. Med. 14(4):914-921; 2010.
110. Yerebakan, C.; Sandica, E.; Prietz, S.; Klopsch, C.; Ugurlucan, M.; Kaminski, A.; Abdija, S.; Lorenzen, B.; Boltze, J.; Nitzsche, B.; Egger, D.; Barten, M.; Furlani, D.; Ma, N.; Vollmar, B.; Liebold, A.; Steinhoff, G. Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload. Cell Transplant. 18(8):855-868; 2009.
111. Yu, G.; Borlongan, C. V.; Stahl, C. E.; Yu, S. J.; Bae, E.; Yang, T.; Zhou, J.; Li, Y.; Xiong, W.; Qin, L.; Zhou, B. Transplantation of human umbilical cord blood cells for the repair of myocardial infarction. Med. Sci. Monit. 14(10):RA163-172; 2008.
112. Zawadzka, M.; Lukasiuk, K.; Machaj, E. K.; Pojda, Z.; Kaminska, B. Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Acta Neurobiol. Exp. (Wars) 69(1):46-51; 2009.
113. Zhao, Z. M.; Li, H. J.; Liu, H. Y.; Lu, S. H.; Yang, R. C.; Zhang, Q. J.; Han, Z. C. Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant. 13(2):113-122; 2004.